AMLX
Price
$1.90
Change
+$0.06 (+3.28%)
Updated
May 20, 9:05 AM EST
80 days until earnings call
SWTX
Price
$44.84
Change
+$0.07 (+0.16%)
Updated
May 17, 6:59 PM EST
72 days until earnings call
Ad is loading...

AMLX vs SWTX

Header iconAMLX vs SWTX Comparison
Open Charts AMLX vs SWTXBanner chart's image
Amylyx Pharmaceuticals
Price$1.90
Change+$0.06 (+3.28%)
Volume$2.8K
CapitalizationN/A
SpringWorks Therapeutics
Price$44.84
Change+$0.07 (+0.16%)
Volume$367.78K
CapitalizationN/A
View a ticker or compare two or three
AMLX vs SWTX Comparison Chart

Loading...

AMLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SWTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AMLX vs. SWTX commentary
May 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and SWTX is a Hold.

COMPARISON
Comparison
May 20, 2024
Stock price -- (AMLX: $1.83 vs. SWTX: $44.84)
Brand notoriety: AMLX and SWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 53% vs. SWTX: 71%
Market capitalization -- AMLX: $124.45M vs. SWTX: $3.32B
AMLX [@Biotechnology] is valued at $124.45M. SWTX’s [@Biotechnology] market capitalization is $3.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 1 FA rating(s) are green whileSWTX’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 1 green, 4 red.
  • SWTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMLX and SWTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while SWTX’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 3 bearish.
  • SWTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SWTX is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +4.27% price change this week, while SWTX (@Biotechnology) price change was +9.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.60%. For the same industry, the average monthly price growth was +5.55%, and the average quarterly price growth was +63.39%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 08, 2024.

SWTX is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+1.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AMLX with price predictions.
OPEN
A.I.dvisor published
a Summary for SWTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SWTX($3.32B) has a higher market cap than AMLX($124M). SWTX YTD gains are higher at: 22.849 vs. AMLX (-87.568).
AMLXSWTXAMLX / SWTX
Capitalization124M3.32B4%
EBITDAN/AN/A-
Gain YTD-87.56822.849-383%
P/E Ratio2.69N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXSWTX
RSI
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
AMLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SWTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSPMX6.240.04
+0.65%
Invesco SteelPath MLP Income R6
IRCZX12.080.06
+0.50%
AB International Small Cap Z
SGIGX31.220.05
+0.16%
Steward Global Equity Income Fund R6
FWMIX62.560.09
+0.14%
American Funds Washington Mutual F3
WGFIX16.51-0.01
-0.06%
William Blair Global Leaders I

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
N/A
ATRA - AMLX
55%
Loosely correlated
+1.06%
IKNA - AMLX
54%
Loosely correlated
+2.14%
SCPX - AMLX
49%
Loosely correlated
+3.40%
OCUL - AMLX
44%
Loosely correlated
-1.59%
JAZZ - AMLX
43%
Loosely correlated
-1.36%
More

SWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SWTX has been loosely correlated with RNA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SWTX jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWTX
1D Price
Change %
SWTX100%
+0.16%
RNA - SWTX
45%
Loosely correlated
+2.72%
XNCR - SWTX
42%
Loosely correlated
+2.54%
FATE - SWTX
41%
Loosely correlated
-5.80%
RLAY - SWTX
41%
Loosely correlated
+2.00%
AMLX - SWTX
40%
Loosely correlated
N/A
More